List of insiders holdings for Aligos Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 2023-11-07 17:16:02 | 11,025,941 0 | 11,025,941 | Form 13G |
| Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 2020-10-28 16:30:44 | 3,547,030 0 | 3,547,030 | Form 13G |
| Novo Holdings A/S 10% Owner | 2022-01-31 16:28:00 | 1,950,000 0 | 1,950,000 | Form 13D |
| Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 2024-02-08 17:44:27 | 1,457,937 0 | 1,457,937 | Form 13D |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2022-02-04 08:53:42 | 1,206,191 0 | 1,206,191 | Form 13G |
| Beigelman Leonid President | 2023-03-17 16:10:27 | 169,500 0 | 169,500 | Form 4 |
| Chavez Margarita Director | 2024-08-09 16:09:21 | 120,000 0 | 120,000 | Form 4 |
| Preston Heather Director | 2024-08-09 16:08:56 | 120,000 0 | 120,000 | Form 4 |
| Achneck Hardean Chief Medical Officer | 2024-10-10 16:16:11 | 75,000 0 | 75,000 | Form 4 |
| McClure Matthew W. Chief Medical Officer | 2024-03-04 17:44:26 | 72,000 0 | 72,000 | Form 4 |
| Martell Bridget A Director | 2024-06-28 16:07:03 | 60,000 0 | 60,000 | Form 4 |
| Scopa James Paul Director | 2024-06-28 16:07:46 | 60,000 0 | 60,000 | Form 4 |
| Nuechterlein Carole Director | 2024-06-28 16:08:13 | 60,000 0 | 60,000 | Form 4 |
| Hirth Peter Director | 2024-06-28 16:08:43 | 60,000 0 | 60,000 | Form 4 |
| Glaub Kathleen Sereda Director | 2020-10-15 17:11:06 | 59,550 0 | 59,550 | Form 3 |
| Quan Lucinda Y. See Remarks | 2023-09-12 16:07:09 | 48,000 0 | 48,000 | Form 4 |
| BLATT LAWRENCE Chief Executive Officer | 2024-09-06 16:23:18 | 33,920 0 | 33,920 | Form 4 |
| Woiwode Thomas Director | 2022-06-27 16:14:41 | 15,000 0 | 15,000 | Form 4 |
| Symons Julian A. See Remarks | 2024-09-06 16:22:44 | 10,880 0 | 10,880 | Form 4 |
| Calhoun Lesley Ann See Remarks | 2024-09-06 16:23:49 | 10,880 0 | 10,880 | Form 4 |
| Nielsen Jack Director | 2024-02-28 17:30:38 | 4,411 0 | 4,411 | Form 4 |
| Moldt Peter Director | 2020-10-15 17:12:25 | 0 0 | 0 | Form 3 |